108 related articles for article (PubMed ID: 10671322)
1. Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine.
Zaman SH; Parent A; Laskey A; Lee MK; Borchelt DR; Sisodia SS; Malinow R
Neurobiol Dis; 2000 Feb; 7(1):54-63. PubMed ID: 10671322
[TBL] [Abstract][Full Text] [Related]
2. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1.
Parent A; Linden DJ; Sisodia SS; Borchelt DR
Neurobiol Dis; 1999 Feb; 6(1):56-62. PubMed ID: 10078973
[TBL] [Abstract][Full Text] [Related]
3. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
[TBL] [Abstract][Full Text] [Related]
4. The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice.
Wen PH; Hof PR; Chen X; Gluck K; Austin G; Younkin SG; Younkin LH; DeGasperi R; Gama Sosa MA; Robakis NK; Haroutunian V; Elder GA
Exp Neurol; 2004 Aug; 188(2):224-37. PubMed ID: 15246822
[TBL] [Abstract][Full Text] [Related]
5. Functional phenotype in transgenic mice expressing mutant human presenilin-1.
Barrow PA; Empson RM; Gladwell SJ; Anderson CM; Killick R; Yu X; Jefferys JG; Duff K
Neurobiol Dis; 2000 Apr; 7(2):119-26. PubMed ID: 10783295
[TBL] [Abstract][Full Text] [Related]
6. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
[TBL] [Abstract][Full Text] [Related]
7. Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: a multi-electrode array study.
Chong SA; Benilova I; Shaban H; De Strooper B; Devijver H; Moechars D; Eberle W; Bartic C; Van Leuven F; Callewaert G
Neurobiol Dis; 2011 Dec; 44(3):284-91. PubMed ID: 21807097
[TBL] [Abstract][Full Text] [Related]
8. Modulation of synaptic plasticity and Tau phosphorylation by wild-type and mutant presenilin1.
Dewachter I; Ris L; Croes S; Borghgraef P; Devijver H; Voets T; Nilius B; Godaux E; Van Leuven F
Neurobiol Aging; 2008 May; 29(5):639-52. PubMed ID: 17222948
[TBL] [Abstract][Full Text] [Related]
9. Facilitated CA1 hippocampal synaptic plasticity in dystrophin-deficient mice: role for GABAA receptors?
Vaillend C; Billard JM
Hippocampus; 2002; 12(6):713-7. PubMed ID: 12542223
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of wild type but not an FAD mutant presenilin-1 promotes neurogenesis in the hippocampus of adult mice.
Wen PH; Shao X; Shao Z; Hof PR; Wisniewski T; Kelley K; Friedrich VL; Ho L; Pasinetti GM; Shioi J; Robakis NK; Elder GA
Neurobiol Dis; 2002 Jun; 10(1):8-19. PubMed ID: 12079399
[TBL] [Abstract][Full Text] [Related]
11. Age-related deficits in long-term potentiation are insensitive to hydrogen peroxide: coincidence with enhanced autophosphorylation of Ca2+/calmodulin-dependent protein kinase II.
Watson JB; Khorasani H; Persson A; Huang KP; Huang FL; O'Dell TJ
J Neurosci Res; 2002 Nov; 70(3):298-308. PubMed ID: 12391589
[TBL] [Abstract][Full Text] [Related]
12. Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis.
Wang R; Dineley KT; Sweatt JD; Zheng H
Neuroscience; 2004; 126(2):305-12. PubMed ID: 15207348
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression.
Sato N; Urano F; Yoon Leem J; Kim SH; Li M; Donoviel D; Bernstein A; Lee AS; Ron D; Veselits ML; Sisodia SS; Thinakaran G
Nat Cell Biol; 2000 Dec; 2(12):863-70. PubMed ID: 11146649
[TBL] [Abstract][Full Text] [Related]
14. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Goto Y; Niidome T; Hongo H; Akaike A; Kihara T; Sugimoto H
Eur J Pharmacol; 2008 Mar; 583(1):84-91. PubMed ID: 18282567
[TBL] [Abstract][Full Text] [Related]
15. Preserved induction of long-term potentiation in the stratum radiatum in the CA1 field of hippocampal slices from transgenic mice overexpressing ornithine decarboxylase and overproducing putrescine.
Pussinen R; Sirviö J; Alhonen L; Larson J; Halmekytö M; Koivisto E; Jänne J
Synapse; 1998 Apr; 28(4):288-93. PubMed ID: 9517837
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice.
Eckert A; Schindowski K; Leutner S; Luckhaus C; Touchet N; Czech C; Müller WE
Neurobiol Dis; 2001 Apr; 8(2):331-42. PubMed ID: 11300728
[TBL] [Abstract][Full Text] [Related]
17. Neurons overexpressing mutant presenilin-1 are more sensitive to apoptosis induced by endoplasmic reticulum-Golgi stress.
Terro F; Czech C; Esclaire F; Elyaman W; Yardin C; Baclet MC; Touchet N; Tremp G; Pradier L; Hugon J
J Neurosci Res; 2002 Aug; 69(4):530-9. PubMed ID: 12210846
[TBL] [Abstract][Full Text] [Related]
18. Impairment in hippocampal long-term potentiation in mice under-expressing the Alzheimer's disease related gene presenilin-1.
Morton RA; Kuenzi FM; Fitzjohn SM; Rosahl TW; Smith D; Zheng H; Shearman M; Collingridge GL; Seabrook GR
Neurosci Lett; 2002 Feb; 319(1):37-40. PubMed ID: 11814648
[TBL] [Abstract][Full Text] [Related]
19. APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1.
Jankowsky JL; Slunt HH; Gonzales V; Jenkins NA; Copeland NG; Borchelt DR
Neurobiol Aging; 2004 Aug; 25(7):885-92. PubMed ID: 15212842
[TBL] [Abstract][Full Text] [Related]
20. Baculoviruses expressing the human familial Alzheimer's disease presenilin 1 mutation lacking exon 9 increase levels of an amyloid beta-like protein in Sf9 cells.
Verdile G; Groth D; Mathews PM; St George-Hyslop P; Fraser PE; Ramabhadran TV; Kwok JB; Schofield PR; Carter T; Gandy S; Martins RN
Mol Psychiatry; 2004 Jun; 9(6):594-602. PubMed ID: 14993906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
